Showing results (1021-1030 of 5,983) with videos related to
Sort By:
Pageof 599
Molecular Cancer Therapeutics|October 15, 2011
GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathwayJeffrey J Wallin, Kyle A Edgar, Jane Guan, et al.Molecular Cancer Therapeutics|October 27, 2011
MUC13 mucin augments pancreatic tumorigenesisSubhash C Chauhan, Mara C Ebeling, Diane M Maher, et al.Molecular Cancer Therapeutics|October 27, 2011
Breast cancer-derived bone metastasis can be effectively reduced through specific c-MET inhibitor tivantinib (ARQ 197) and shRNA c-MET knockdownSara Previdi, Giovanni Abbadessa, Francesca Dalò, et al.Molecular Cancer Therapeutics|October 27, 2011
A 71-gene signature of TRAIL sensitivity in cancer cellsJun-Jie Chen, Steen Knudsen, Wiktor Mazin, et al.Molecular Cancer Therapeutics|December 3, 2011
Evaluation of the antitumor effects and mechanisms of PF00299804, a pan-HER inhibitor, alone or in combination with chemotherapy or targeted agents in gastric cancerHyun-Jin Nam, Keith A Ching, Julie Kan, et al.Molecular Cancer Therapeutics|September 3, 2011
Discovery and evaluation of inhibitors of human ceramidaseJeremiah M Draper, Zuping Xia, Ryan A Smith, et al.Molecular Cancer Therapeutics|December 29, 2011
Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancerJing Chen, Jieqiong Wang, Lei Lin, et al.Molecular Cancer Therapeutics|December 29, 2011
Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolitesRyan Montano, Injae Chung, Kristen M Garner, et al.Molecular Cancer Therapeutics|March 15, 2012
HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancerFeng Su, Victor Grijalva, Kaveh Navab, et al.Molecular Cancer Therapeutics|February 24, 2012
The ubiquitin-proteasome system meets angiogenesisNader RahimiPageof 599